| Home > Publications database > Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. > Access to Fulltext |
| Restricted | |
American J Hematol - 2024 - Kaulen - Toxicities and outcome after CD19‐directed chimeric antigen receptor T‐cell therapy
|
|
| version 1 | |